Core Insights - Cibus has demonstrated promising results in its third mode of action for Sclerotinia resistance in canola, which is expected to help preserve crop yields and reduce fungicide usage for farmers [1][4] - The company's Rapid Trait Development System™ (RTDS) allows for efficient gene editing and development of plant traits that are indistinguishable from conventional breeding [2][7] - Cibus has completed edits in four modes of action for Sclerotinia resistance and anticipates completing field tests by the end of 2025 [3] Company Overview - Cibus is a technology company focused on gene editing to develop and license traits to seed companies, addressing productivity and sustainability challenges in agriculture [6][7] - The company is not a seed company but rather licenses its traits for royalties on seed sales, with a focus on major global row crops like canola, rice, and soybean [7] - Cibus aims to develop traits at a fraction of the time and cost compared to conventional breeding, with a current pipeline that includes productivity traits for weed management and disease resistance [7] Industry Context - Sclerotinia sclerotiorum is a significant fungal pathogen affecting canola and other crops, causing yield losses of 7-15% and potentially up to 90% in severe cases [5] - The economic impact of diseases and pests in agriculture is estimated to cost the global economy approximately $300 billion annually, highlighting the importance of Cibus' innovations [6][7] - The development of durable resistance traits is crucial as climate change continues to affect crop diseases and their geographic distribution [4][5]
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola